Janet K. Peper

Luebeck, SH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Immunotherapy decision coaching for people with multiple sclerosis - Implementation of an interprofessional decision support programme into clinical practice.

Immunotherapy decision coaching for people with multiple sclerosis - Implementation of an interprofessional decision support programme into clinical practice.

Journal: Multiple sclerosis and related disorders

Published: July 16, 2025

Erratum to "Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster-randomised controlled trial and mixed methods process evaluation" [Patient Educ Couns 125 (2024) 108293].

Erratum to "Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster-randomised controlled trial and mixed methods process evaluation" [Patient Educ Couns 125 (2024) 108293].

Journal: Patient education and counseling

Published: November 13, 2024

Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster- randomised controlled trial and mixed methods process evaluation.

Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - A cluster- randomised controlled trial and mixed methods process evaluation.

Journal: Patient education and counseling

Published: November 13, 2023

Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models.

Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models.

Journal: The Journal of experimental medicine

Published: June 25, 2019

Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer.

Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer.

Journal: Frontiers in immunology

Published: November 27, 2018

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.

Journal: Blood

Published: July 31, 2018

The immunopeptidomic landscape of ovarian carcinomas.

The immunopeptidomic landscape of ovarian carcinomas.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 03, 2017

The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy.

The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy.

Journal: Acta neuropathologica

Published: April 29, 2017

Identification of Immunogenic Epitopes by MS/MS.

Identification of Immunogenic Epitopes by MS/MS.

Journal: Cancer journal (Sudbury, Mass.)

Published: April 15, 2017

Human CD8(+) T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase.

Human CD8(+) T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase.

Journal: Viral immunology

Published: April 13, 2016

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.

HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy.

Journal: Oncoimmunology

Published: April 01, 2016

Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer.

Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 25, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026